Filters close
Newswise: Researchers Create Rapid Test for Deadly Infections in Livestock
Released: 10-Jun-2022 9:55 AM EDT
Researchers Create Rapid Test for Deadly Infections in Livestock
McMaster University

Researchers at McMaster University have developed a new form of rapid test to detect infections in farm animals, responding to the rising threat of dangerous outbreaks.

Newswise: Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
9-Jun-2022 12:05 AM EDT
Going all the way: Scientists prove that inhaled vaccines offer better protection and immunity than nasal sprays
McMaster University

McMaster University scientists who compared respiratory vaccine-delivery systems have confirmed that inhaled aerosol vaccines provide far better protection and stronger immunity than nasal sprays.

Newswise: Older Persons with Type 1 Diabetes Face Risk of Reduced Muscle Strength and More Cardiovascular Issues, Researchers Find
Released: 9-Jun-2022 9:05 PM EDT
Older Persons with Type 1 Diabetes Face Risk of Reduced Muscle Strength and More Cardiovascular Issues, Researchers Find
McMaster University

Older adults with Type 1 diabetes (T1D) are at significantly higher risk of both muscle weakening and cardiovascular complications, say McMaster University researchers

Released: 8-Jun-2022 11:05 AM EDT
Rapid, Reliable Test for COVID and Other Infections, Created by McMaster Researchers, Moves Toward Marketplace
McMaster University

McMaster University researchers behind a new form of rapid, accurate and portable diagnostic test are moving their work toward the marketplace.

   
Newswise: Radiotherapy Not Always Needed for Early Breast Cancer
6-Jun-2022 10:20 AM EDT
Radiotherapy Not Always Needed for Early Breast Cancer
McMaster University

McMaster researchers tracked 501 patients with luminal A breast cancer for five years post-surgery and found the recurrence of cancer in the breast was just 2.3 per cent without radiotherapy. This was roughly comparable with a 1.9 per cent risk this patient sample had of developing a new breast cancer in their other untreated breast.

Released: 26-May-2022 1:05 PM EDT
Prone positioning may not be helpful for all awake hypoxemic COVID-19 patients
McMaster University

At the beginning of the COVID-19 pandemic, prone positioning was believed to be a potentially useful intervention – one that warranted further investigation. While some studies suggested awake prone positioning was safe, there was insufficient evidence to recommend using this strategy in clinical guidelines. COVI-PRONE, designed to provide robust evidence, included 21 hospitals in Canada, Saudi Arabia, Kuwait, and the United States. Researchers aimed to use prone positioning in hypoxemic COVID-19 patients for 8 to 10 hours per day, with 2 to 3 breaks, as needed. Participants in the control group were not proned and were asked not to position themselves in the prone position.

Released: 17-May-2022 2:30 PM EDT
Type-I interferon stops immune system ‘going rogue’ during viral infections
McMaster University

McMaster University researchers have discovered that Type I interferon (IFN) plays a key role in helping the immune system effectively target viruses, while stopping white blood cells from ‘going rogue’ and attacking the body’s own organs.

Newswise: Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find
3-May-2022 5:05 PM EDT
Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find
McMaster University

McMaster University researchers who study the dynamics of infectious disease transmission have investigated the population-level consequences of a potentially significant––and unobvious––benefit of wearing masks.

Newswise: New Cardiac Defibrillator Much Safer for Patients: Study
Released: 30-Apr-2022 9:00 AM EDT
New Cardiac Defibrillator Much Safer for Patients: Study
McMaster University

A study has demonstrated that a new type of cardiac defibrillator called a subcutaneous ICD (S-ICD) reduced patient complications by more than 90 percent, compared to the TV-ICD. The study involved 544 eligible patients (one-quarter females) with average age of 49, at 14 clinical centres in Canada

Newswise: Energy-burning brown fat less active in boys with obesity
Released: 14-Apr-2022 11:05 AM EDT
Energy-burning brown fat less active in boys with obesity
McMaster University

The researchers of McMaster’s Centre for Metabolism, Obesity and Diabetes Research performed MRI scans to measure BAT activity in 26 boys between the ages of eight and 10. They studied the BAT tissue in the neck before and after one hour of exposure to a cold suit set at a temperature of 18 degrees Celsius. The patient sample included 13 boys with a normal BMI and the same number again with obesity, in the first study of its kind in children.

Newswise: Regular cycling helps patients with ‘accelerated aging’ disease
Released: 11-Apr-2022 11:05 AM EDT
Regular cycling helps patients with ‘accelerated aging’ disease
McMaster University

Cycling for 35 minutes three times a week for 12 weeks led to a 32 per cent increase in overall fitness in people with MD. Patients who took part in the study also saw a 1.6-kilogram increase in their muscle mass and a two per cent reduction of body fat. They were also able to walk an extra 47 metres in six minutes, when tested by researchers at the end of the 12-week trial. Eleven patients took part in the study.

31-Mar-2022 4:20 PM EDT
Major bleeding reduced in patients having non-cardiac surgery
McMaster University

The drug tested, tranexamic acid (TXA), was given to patients at risk of bleeding or vascular complications. The study found that TXA did not increase deep vein clotting known as VTE, heart attack, non-hemorrhagic stroke, or other major vascular complication in the 30 days after surgery. In the study, half of 9,535 patients in 22 countries were randomly assigned TXA, half placebo. Patients were 45 years or older (average age 69 years); 44% of them were female.

Newswise: Researchers re-engineer red blood cells to trigger immune system against COVID-19
10-Mar-2022 10:00 AM EST
Researchers re-engineer red blood cells to trigger immune system against COVID-19
McMaster University

McMaster researchers have been able to re-engineer red blood cells and use them as a promising new vehicle for vaccine delivery.

Newswise: Better assessment of risk from heart surgery results in better patient outcomes
28-Feb-2022 8:05 AM EST
Better assessment of risk from heart surgery results in better patient outcomes
McMaster University

This study, published in the New England Journal of Medicine, assessed patients having heart surgery, measured troponin before and daily for the first few days after surgery, and assessed death and the incidence of major vascular complications – such as heart attack, stroke or life-threatening blood clot – after heart surgery. The study involved 15,984 adult patients with an average age just over 63 years undergoing cardiac surgery. Patients were from 12 countries, with more than a third of the countries being outside of North America and Europe.

Newswise: Now THAT's a wrap
Released: 28-Feb-2022 11:05 AM EST
Now THAT's a wrap
McMaster University

New research by the inventors of a promising pathogen-repellent wrap has confirmed that it sheds not only bacteria, as previously proven, but also viruses, boosting its potential usefulness for interrupting the transmission of infections.

Newswise: Scientists Discover How Caffeine Protects Against Cardiovascular Disease
Released: 9-Feb-2022 10:05 PM EST
Scientists Discover How Caffeine Protects Against Cardiovascular Disease
McMaster University

Scientists have a new understanding of the protective effects of caffeine on the cardiovascular system. While its stimulant effects have long been characterized, a team of McMaster University researchers have discovered how caffeine interacts with key cellular factors to remove cholesterol from the bloodstream.

Newswise: No needle required: Researchers confirm newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants of concern
Released: 9-Feb-2022 6:05 AM EST
No needle required: Researchers confirm newly developed inhaled vaccine delivers broad protection against SARS-CoV-2, variants of concern
McMaster University

Scientists at McMaster University who have developed an inhaled form of COVID vaccine have confirmed it can provide broad, long-lasting protection against the original strain of SARS-CoV-2 and variants of concern. The research, recently published in the journal Cell, reveals the immune mechanisms and significant benefits of vaccines being delivered directly into the respiratory tract, rather than by traditional injection.

Newswise: Two for one: Repeated seasonal influenza vaccines also provide kids better protection against future flu pandemics, researchers find
1-Feb-2022 10:55 AM EST
Two for one: Repeated seasonal influenza vaccines also provide kids better protection against future flu pandemics, researchers find
McMaster University

Researchers at McMaster University have found that children who receive years of season-specific flu vaccines develop antibodies that also provide broader protection against new strains, including those capable of causing pandemics.



close
0.14364